Profit Or Loss [Abstract]

Egetis Therapeutics - Filing #678413

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
576,000,000 SEK
226,000,000 SEK
Cost of sales
110,000,000 SEK
63,000,000 SEK
Other income
- SEK
- SEK
Profit (loss) from operating activities
3,248,000,000 SEK
1,981,000,000 SEK
Finance income
49,000,000 SEK
50,000,000 SEK
Finance costs
42,000,000 SEK
7,000,000 SEK
Profit (loss) before tax
3,268,000,000 SEK
1,938,000,000 SEK
Tax expense (income)
1,000,000 SEK
- SEK
Profit (loss)
3,269,000,000 SEK
1,938,000,000 SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
13.0
10.0
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
13.0
10.0

Talk to a Data Expert

Have a question? We'll get back to you promptly.